Bio-Techne Corporation (TECH)

NASDAQ: TECH · Real-Time Price · USD
49.78
+1.03 (2.11%)
May 8, 2025, 4:00 PM EDT - Market closed
2.11%
Market Cap 7.87B
Revenue (ttm) 1.21B
Net Income (ttm) 131.63M
Shares Out 158.09M
EPS (ttm) 0.83
PE Ratio 59.98
Forward PE 24.53
Dividend $0.32 (0.64%)
Ex-Dividend Date Feb 14, 2025
Volume 4,635,489
Open 48.15
Previous Close 48.75
Day's Range 47.51 - 50.74
52-Week Range 46.44 - 85.57
Beta 1.46
Analysts Buy
Price Target 73.88 (+48.41%)
Earnings Date May 7, 2025

About TECH

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera,... [Read more]

Industry Biotechnology
Sector Healthcare
IPO Date Feb 9, 1989
Employees 3,050
Stock Exchange NASDAQ
Ticker Symbol TECH
Full Company Profile

Financial Performance

In 2024, Bio-Techne's revenue was $1.16 billion, an increase of 1.97% compared to the previous year's $1.14 billion. Earnings were $168.07 million, a decrease of -41.07%.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for TECH stock is "Buy." The 12-month stock price forecast is $73.88, which is an increase of 48.41% from the latest price.

Price Target
$73.88
(48.41% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing

Kytopen and Bio-Techne announce partnership on an integrated cellular engineering workflow to expedite cell therapy manufacturing. The TcBuster™ system offers a fast and scalable method to integrate l...

15 hours ago - PRNewsWire

Bio-Techne to Present at the BofA Securities 2025 Health Care Conference

MINNEAPOLIS , May 8, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the BofA Securities 2025 Heal...

18 hours ago - PRNewsWire

Bio-Techne Corporation (TECH) Q3 2025 Earnings Call Transcript

Bio-Techne Corporation (NASDAQ:TECH) Q3 2025 Earnings Conference Call May 7, 2025 9:00 AM ET Company Participants David Clair - Vice President-Investor Relations Kim Kelderman - President & Chief Exe...

1 day ago - Seeking Alpha

Bio-Techne exceeds profit expectations, announces new share buyback plan

Bio-Techne on Wednesday beat Wall Street estimates for third-quarter profit, driven by growth in its unit that provides proteins, antibodies and other products for research and said it is launching a ...

1 day ago - Reuters

BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM

MINNEAPOLIS , May 7, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended March 31, 2...

1 day ago - PRNewsWire

BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS

MINNEAPOLIS , May 7, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ending March 31, 2025. Third Quarter FY2025 Highlights Third ...

1 day ago - PRNewsWire

ScaleReady awards a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc.

ST. PAUL, Minn. , May 6, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf, Bio-Techne Corporation and CellReady, today announced that A2 Biotherapeutics, Inc. ("A2") has been awarded...

2 days ago - PRNewsWire

ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy

ST. PAUL, Minn. , April 29, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that March Biosciences has been awar...

9 days ago - PRNewsWire

Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection

New assay enables high-resolution spatial visualization of protein interactions, unlocking functional insights within complex tissues MINNEAPOLIS , April 24, 2025 /PRNewswire/ -- Bio-Techne Corporatio...

14 days ago - PRNewsWire

Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting

MINNEAPOLIS , April 23, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its latest advancements in cancer research tools at the 2025 American Association fo...

15 days ago - PRNewsWire

Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument

MINNEAPOLIS , April 2, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced an expansion of the longstanding partnership between its spatial biology brand, Advanced Cell Diagnost...

5 weeks ago - PRNewsWire

Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany

MINNEAPOLIS , March 26, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will open a new Customer Experience Centre in Düsseldorf, Germany to serve customers across the Eu...

6 weeks ago - PRNewsWire

Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting

MINNEAPOLIS , March 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care by le...

6 weeks ago - PRNewsWire

Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System

MINNEAPOLIS , March 10, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it has begun shipping the Leo™ System, powered by Simple Western™ Technology. Leo expands upon e...

2 months ago - PRNewsWire

Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes

AmplideX® Nanopore Carrier Plus Kit uses nanopore sequencing to resolve high-prevalence genes. MINNEAPOLIS and OXFORD, England , March 3, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) tod...

2 months ago - PRNewsWire

Bio-Techne: Attractive Markets And A Good Moat, But Valuation Is Seldom A Bargain

Bio-Techne's shares have been pressured lately on concerns about the academic research market and biopharma R&D restructuring, but core business trends look largely intact. Fiscal Q2 showed revenue gr...

2 months ago - Seeking Alpha

Bio-Techne to Present at Investor Conferences

MINNEAPOLIS , Feb. 27, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences: TD Cowen 45th Annual Health Care Conferenc...

2 months ago - PRNewsWire

Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology

MINNEAPOLIS , Feb. 20, 2025 /PRNewswire/ -- Bio-Techne (NASDAQ: TECH), a global leader in life science tools and reagents, today announced the launch of an expanded menu of human and mouse RNAscope™ i...

2 months ago - PRNewsWire

Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System

MINNEAPOLIS , Feb. 18, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a leading provider of innovative life science research tools, is pleased to announce the official release of GMP Tran...

2 months ago - PRNewsWire

Bio-Techne Corporation (TECH) Q2 2025 Earnings Call Transcript

Bio-Techne Corporation (NASDAQ:TECH) Q2 2025 Earnings Conference Call February 5, 2025 9:00 AM ET Company Participants David Clair - Vice President-Investor Relations Kim Kelderman - President and Ch...

3 months ago - Seeking Alpha

Bio-Techne Declares Dividend

MINNEAPOLIS , Feb. 5, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended December 3...

3 months ago - PRNewsWire

Bio-Techne Releases Second Quarter Fiscal 2025 Results

MINNEAPOLIS , Feb. 5, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ending December 31, 2024. Second Quarter FY2025 Highlights ...

3 months ago - PRNewsWire

Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors

MINNEAPOLIS , Feb. 4, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Amy E. Herr, Ph.D.

3 months ago - PRNewsWire

ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio

ST. PAUL, Minn. , Jan. 21, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that BrainChild Bio has been awarded ...

3 months ago - PRNewsWire

Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results

MINNEAPOLIS , Jan. 21, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, February 5, 2025, at 8:00 a.m. C...

3 months ago - PRNewsWire